Carlos Angulo

March 21, 2016 | National Law Journal

Congress enabled their speedy approval in 2010, but courts and the FDA will determine how fast they move.

By Carlos Angulo

13 minute read

September 10, 2007 | National Law Journal

The D.C. Circuit rejected the Abigail Alliance's campaign to alter the current FDA drug approval regime, thereby preserving the integrity of the clinical testing program that is critical to the FDA's mission to promote the public health.

By William Schultz and Carlos Angulo

9 minute read